Company Filing History:
Years Active: 2016
Title: Klaus-Michael Wilsmann: Innovator in Hormonal Contraceptives
Introduction
Klaus-Michael Wilsmann is a notable inventor based in Roetgen, Germany. He has made significant contributions to the field of hormonal contraceptives, showcasing his expertise and innovative spirit. His work has led to the development of a unique contraceptive formulation that addresses women's health needs.
Latest Patents
Wilsmann holds a patent for a hormonal contraceptive that includes a combination of ethinyloestradiol and chlormadinone acetate. This invention features 21 to 25 hormone-containing daily units, which contain ethinyloestradiol in an amount of ≥25 µg and chlormadinone acetate in an amount of ≥5 mg. Additionally, it may include 7 to 3 hormone-free daily units for oral administration to women. This patent reflects his commitment to advancing women's health through innovative solutions.
Career Highlights
Throughout his career, Klaus-Michael Wilsmann has been associated with Richter Gedeon Nyrt., a prominent company in the pharmaceutical industry. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in hormonal contraceptives.
Collaborations
Wilsmann has worked alongside notable colleagues such as Janine Klose and Johannes Bartholomäus. Their collaborative efforts have played a crucial role in the development of effective contraceptive solutions.
Conclusion
Klaus-Michael Wilsmann's contributions to the field of hormonal contraceptives highlight his innovative approach and dedication to improving women's health. His patent and collaborations reflect a commitment to advancing medical science and providing effective solutions for women.